- Assistant Professor, CWRU School of Medicine
Sahera Dirajlal-Fargo, DO, is a physician in the Division of Pediatric Infectious Diseases and Rheumatology at University Hospitals Rainbow Babies & Children’s Hospital and Instructor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Dirajlal-Fargo is board certified in pediatrics and pediatric infectious diseases. Her special interest is pediatric infectious diseases, particularly pediatric HIV infection. She was named to the UH Rainbow Babies & Children’s Hospital staff in 2013.
She holds a bachelor’s degree from Carroll College, Waukesha, Wis., and a master’s degree in neuroscience from Medical College of Wisconsin, Wauwatosa, Wis. She earned a doctorate in osteopathic medicine from University of New England College of Osteopathic Medicine, Biddeford, Maine.
Dr. Dirajlal-Fargo completed her residency in pediatrics at Phoenix Children’s Hospital and Maricopa Integrated Health System, Phoenix, Ariz. She served a fellowship in pediatric infectious disease at Children’s National Medical Center, Washington, DC, and during this time was a medical reviewer for the Division of Vaccines and Related Product Applications, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Md.
In 2009 and 2010 Dr. Dirajlal-Fargo was a Pediatric Aids Corps Physician with the Baylor International Pediatric AIDS Initiative and worked at the Pediatric HIV Outreach Clinic, both in Malawi, Africa. Her research interest is in cardiovascular complications in pediatric HIV infection and in HIV in sub-Saharan Africa.
Dr. Dirajlal-Fargo has published in peer-reviewed journals and presented at national and international pediatric medicine meetings and symposiums. She is a member of the International AIDS Society, Pediatric Infectious Disease Society and Infectious Disease Society of America.
In addition to English, Dr. Dirajlal-Fargo is fluent in French and Spanish.
Cardiovascular complications in pediatric HIV infection
IV in sub-Saharan Africa
- Pediatric HIV Research in Sub-Saharan Africa
English, French, Spanish
- Pediatric Infectious Diseases - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - Children's National Medical Center (2010 - 2013)
Residency | Pediatrics
Pediatrics - Phoenix Children's Hospital (2006 - 2009)
University Of New England College Of Osteopathic Medicine (2006)
Medical College Of Wisconsin (2002)
Carroll University (1999)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sahera Dirajlal-Fargo did not disclose any Outside Relationships with Industry.